Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment
published in: British Journal of Cancer
date of publication: 2019-12-17
main subject: docetaxel, mebendazole
Cites articles 43
- 2017-01-05
Date
Title
Article - wd:Q92025247